CRISPR activation and interference screens decode stimulation responses in primary human T cells

Author:

Schmidt Ralf12ORCID,Steinhart Zachary12ORCID,Layeghi Madeline1ORCID,Freimer Jacob W.123ORCID,Bueno Raymund2ORCID,Nguyen Vinh Q.4,Blaeschke Franziska12ORCID,Ye Chun Jimmie12567ORCID,Marson Alexander12589ORCID

Affiliation:

1. Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA.

2. Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

3. Department of Genetics, Stanford University, Stanford, CA 94305, USA.

4. Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.

5. Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

6. Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA 94129, USA.

7. Institute for Human Genetics, University of California San Francisco, San Francisco, CA 94143, USA.

8. Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.

9. Diabetes Center, University of California San Francisco, San Francisco, CA 94143, USA.

Abstract

Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-γ (IFN-γ) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3